3 days ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Recommendation of “Moderate Buy” from AnalystsMarketBeat
Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the six ratings firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has ra…
Nasdaq 100 · Pharmaceuticals · Science
X